CUSIP 68277Q105COM CL AOKURQ4 2025
29 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Acorn Capital Advisors, LLC | 2.84M | $8.24M |
| 2 | Adar1 Capital Management, LLC | 1.01M | $2.94M |
| 3 | Prosight Management, LP | 816.9K | $2.37M |
| 4 | Shay Capital LLC | 780.9K | $2.26M |
| 5 | Rosalind Advisors, Inc. | 730.5K | $2.12M |
| 6 | Vestal Point Capital, LP | 635.0K | $1.84M |
| 7 | Vanguard Group Inc | 626.6K | $1.82M |
| 8 | Highbridge Capital Management LLC | 542.4K | $1.57M |
| 9 |
| 4 | Jan 30, 2026 | The Vanguard Group | 13G/A | 4.9% | 626.6K | SEC |
| 5 | Nov 28, 2025 | Prosight Management, LP | 13G | 11.0% | 745.6K | SEC |
| 6 | Aug 14, 2025 | Samsara Biocapital, L.P. | 13G/A | — | 913.30M | SEC |
| 7 | Aug 14, 2025 | Cantor Fitzgerald Securities | 13G | 11.0% | 669.5K | SEC |
| 8 | Aug 14, 2025 | Perceptive Advisors LLC | 13G/A | — | 591.1K | SEC |
| 9 | Aug 14, 2025 | Highbridge Capital Management, LLC | 13G | 5.2% | 663.6K | SEC |
| 10 | May 30, 2025 | Acorn Bioventures, L.P. | 13D/A | 22.1% | — | SEC |
See the full Schedule 13D/13G history for Onkure Therapeutics Inc.
Unlock full history| Nea Management Company, LLC |
| 478.5K |
| $1.39M |
| 10 | Stepstone Group LP | 491.9K | $1.35M |